BX BIOGENIX HEALTH & NUTRITION
Olimp Laboratories sp. z o.o.
Application Filed: 2014-03-04
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 86210255 |
| Registration Number | 4879309 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
| Domestic Representative | Howard N. Aronson |
| Attorney Name | Howard N. Aronson |
| Attorney Docket Number | 17274 |
| Law Office Assigned | M80 |
| Employee Name | CANTOR, JILLIAN REDDIN |
Timeline
| 2014-03-04 | Application Filed |
| 2015-10-20 | Published for Opposition |
| 2016-01-05 | Location: PUBLICATION AND ISSUE SECTION |
| 2016-01-05 | Status: Live/Registered |
| 2016-01-05 | Trademark Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Olimp Laboratories sp. z o.o. |
| Address | Nagawczyna 109c Debica PL PL-39-200 |
| Legal Entity Type | Limited Liability Company |
| Legal Entity State | PL |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 261126 | Oblongs as carriers for words, letters or designs |
| 261127 | Oblongs not used as carriers for words, letters or designs |
| 261321 | Quadrilaterals that are completely or partially shaded |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 29 |
| U.S. Codes: | 046 |
| International Codes: | 30 |
| U.S. Codes: | 046 |
| International Codes: | 32 |
| U.S. Codes: | 045,046,048 |
| Type Code | Type |
|---|---|
| CC0000 | The color(s) dark blue, blue, orange, gray and white is/are claimed as a feature of the mark. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2014-03-07 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2014-03-15 | 2 NWOS I:Incoming Correspondence |
| NOTICE OF DESIGN SEARCH CODE E-MAILED | 2014-03-18 | 3 MDSM E:E-Mail |
| ASSIGNED TO EXAMINER | 2014-06-09 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2014-06-16 | 5 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2014-06-16 | 6 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2014-06-16 | 7 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2014-12-14 | 8 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2014-12-29 | 9 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2014-12-30 | 10 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2014-12-30 | 11 TEME I:Incoming Correspondence |
| FINAL REFUSAL WRITTEN | 2015-01-22 | 12 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2015-01-22 | 13 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2015-01-22 | 14 GNFN O:Outgoing Correspondence |
| SUBSEQUENT FINAL REFUSAL WRITTEN | 2015-01-30 | 15 CFRC R:Renewal |
| SUBSEQUENT FINAL EMAILED | 2015-01-30 | 16 GNSF O:Outgoing Correspondence |
| NOTIFICATION OF SUBSEQUENT FINAL EMAILED | 2015-01-30 | 17 GNS1 O:Outgoing Correspondence |
| EXPARTE APPEAL RECEIVED AT TTAB | 2015-07-30 | 18 EXAF T:TTAB Proceeding |
| JURISDICTION RESTORED TO EXAMINING ATTORNEY | 2015-07-30 | 19 JURT T:TTAB Proceeding |
| EX PARTE APPEAL-INSTITUTED | 2015-07-30 | 20 EXPI T:TTAB Proceeding |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2015-07-30 | 21 ERFR I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2015-08-07 | 22 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2015-08-07 | 23 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2015-09-03 | 24 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2015-09-03 | 25 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2015-09-03 | 26 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2015-09-03 | 27 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2015-09-03 | 28 CNSA O:Outgoing Correspondence |
| EXPARTE APPEAL TERMINATED | 2015-09-03 | 29 EXPT T:TTAB Proceeding |
| ASSIGNED TO LIE | 2015-09-08 | 30 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2015-09-14 | 31 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2015-09-30 | 32 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2015-10-20 | 33 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2015-10-20 | 34 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2016-01-05 | 35 R.PR A:Allowance for Publication |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2021-01-05 | 36 REM1 E:E-Mail |
| CANCELLED SEC. 8 (6-YR) | 2022-07-15 | 37 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 BX BIOGENIX HEALTH & NUTRITION 86210255 4879309 Live/Registered |
Olimp Laboratories sp. z o.o. 2014-03-04 |
 BX BIOGENIX HEALTH & NUTRITION 79015641 3247703 Dead/Cancelled |
OLIMP LABORATORIES Sp. z o.o 2005-07-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 